Literature DB >> 25098956

Reply to: Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise.

Eugenia Gkaliagkousi1, Eleni Gavriilaki, Stella Douma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25098956      PMCID： PMC8031634          DOI： 10.1111/jch.12391

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

1.  Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Authors:  Stephane Laurent; John Cockcroft; Luc Van Bortel; Pierre Boutouyrie; Cristina Giannattasio; Daniel Hayoz; Bruno Pannier; Charalambos Vlachopoulos; Ian Wilkinson; Harry Struijker-Boudier
Journal:  Eur Heart J       Date:  2006-09-25       Impact factor: 29.983

2.  Elevated levels of MMP-9 in untreated patients with stage I essential hypertension.

Authors:  Eugenia Gkaliagkousi; Michail Doumas; Eleni Gavriilaki; Areti Triantafyllou; Konstantinos Vogiatzis; Panagiota Anyfanti; Konstantinos Petidis; Stella Douma
Journal:  Clin Exp Hypertens       Date:  2012-05-10       Impact factor: 1.749

3.  Association between cardiotrophin 1 levels and central blood pressure in untreated patients with essential hypertension.

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Barbara Nikolaidou; Fani Chatzopoulou; Panagiota Anyfanti; Areti Triantafyllou; Konstantinos Petidis; Chrysanthos Zamboulis; Stella Douma
Journal:  Am J Hypertens       Date:  2014-01-08       Impact factor: 2.689

Review 4.  ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing).

Authors:  R J Gibbons; G J Balady; J W Beasley; J T Bricker; W F Duvernoy; V F Froelicher; D B Mark; T H Marwick; B D McCallister; P D Thompson; W L Winters; F G Yanowitz; J L Ritchie; R J Gibbons; M D Cheitlin; K A Eagle; T J Gardner; A Garson; R P Lewis; R A O'Rourke; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1997-07       Impact factor: 24.094

5.  Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: the effect of treatment with an angiotensin II receptor blocker.

Authors:  E Gavriilaki; E Gkaliagkousi; B Nikolaidou; G Triantafyllou; F Chatzopoulou; S Douma
Journal:  J Hum Hypertens       Date:  2014-03-13       Impact factor: 3.012

6.  Platelet activation in essential hypertension during exercise: pre- and post-treatment changes with an angiotensin II receptor blocker.

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Efi Yiannaki; Dimitra Markala; Nikolaos Papadopoulos; Areti Triantafyllou; Panagiota Anyfanti; Konstantinos Petidis; Vasileia Garypidou; Michael Doumas; Albert Ferro; Stella Douma
Journal:  Am J Hypertens       Date:  2013-08-23       Impact factor: 2.689

7.  Seeing the forest, but not the trees: pertinent considerations for examining acute changes in pulse wave velocity in response to pharmaceutical interventions and exercise.

Authors:  Aaron A Phillips
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-08-16       Impact factor: 3.738

8.  Exercise-induced pulse wave velocity changes in untreated patients with essential hypertension: the effect of an angiotensin receptor antagonist.

Authors:  Eugenia Gkaliagkousi; Eleni Gavriilaki; Barbara Nikolaidou; George Triantafyllou; Stella Douma
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-05-22       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.